# The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia

> **NCT06307600** · EARLY_PHASE1 · RECRUITING · sponsor: **Anhui Provincial Hospital** · enrollment: 9 (estimated)

## Conditions studied

- B Lymphoblastic Leukemia/Lymphoma

## Interventions

- **DRUG:** RD06-03 cell injection

## Key facts

- **NCT ID:** NCT06307600
- **Lead sponsor:** Anhui Provincial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-15
- **Primary completion:** 2025-03-15
- **Final completion:** 2027-04-01
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2025-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06307600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06307600, "The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06307600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*